Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author González-Medina M.ca
• dc.contributor.author Curto-Barredo, Laiaca
• dc.contributor.author Labrador-Horrillo, Moisésca
• dc.contributor.author Giménez Arnau, Anna Mariaca
• dc.date.accessioned 2018-01-25T10:30:04Z
• dc.date.issued 2017
• dc.format.mimetype application/pdf
• dc.identifier.citation González-Medina M, Curto-Barredo L, Labrador-Horrillo M, Giménez-Arnau A. Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases. J Eur Acad Dermatol Venereol. 2017 May;31(5):e245-e246. DOI: 10.1111/jdv.14034
• dc.identifier.doi http://dx.doi.org/10.1111/jdv.14034
• dc.identifier.issn 0926-9959
• dc.identifier.uri http://hdl.handle.net/10230/33747
• dc.language.iso eng
• dc.publisher Wileyca
• dc.relation.ispartof Journal of the European Academy of Dermatology and Venereology. 2017 May;31(5):e245-6
• dc.rights This is the peer reviewed version of the following article: onzález-Medina M, Curto-Barredo L, Labrador-Horrillo M, Giménez-Arnau A. Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases. J Eur Acad Dermatol Venereol. 2017 May;31(5):e245-e246, which has been published in final form at http://dx.doi.org/10.1111/jdv.14034. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.subject.keyword Omalizumab
• dc.subject.other Urticària
• dc.subject.other Embaràs -- Complicacions
• dc.title Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two casesca
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/acceptedVersion